So, while HIF-1α antagonizes c-MYC-induced proliferation, HIF-2α increases it by potentiating the oncogenic effect of c-MYC in an in vitro model with VHL-deficient renal cell carcinoma [108]. The gene discussed is MYC; the disease is renal cell carcinoma.